[1]
Rollet, E. et al. 2025. Successful Immunotherapy Rechallenge Without Recurrence of Hemophagocytic Lymphohistiocytosis in a Patient With Metastatic Endometrial Cancer Previously Treated With Dostarlimab. World Journal of Oncology. (Oct. 2025). DOI:https://doi.org/10.14740/wjon2661.